Drug profile · INN
rifabutin
MYCOBUTIN
rifabutin (MYCOBUTIN) is a bacterial dna-directed rna polymerase inhibitor. Associated with Pfizer Australia Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — rifabutin
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 11
- Programs
- 1
- Data quality
- 0.84
Quick answer
rifabutin (MYCOBUTIN) is a bacterial dna-directed rna polymerase inhibitor. Associated with Pfizer Australia Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial DNA-directed RNA polymerase inhibitor
Primary target: Bacterial DNA-directed RNA polymerase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 11931463
All-in-one fixed-dose combination for treating Helicobacter pylori infection
granted -
US 11878011
Method for eradicating Helicobacter pylori infection in patients regardless of body mass index
granted -
US 11135172
Rifabutin-based compositions and methods for treating Helicobacter pylori infection
granted -
US 11090326
Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimine
granted -
US 10238606
Pharmaceutical compositions for the treatment of Helicobacter pylori
granted -
US 10143702
Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimine
granted -
US 9603806
Pharmaceutical compositions for the treatment of Helicobacter pylori
granted -
US 9498445
Pharmaceutical compositions for the treatment of Helicobacter pylori
granted -
US 9314477
Compositions comprising rifabutin, clarithromycin, and clofazimine and uses thereof
granted -
US 9198926
Methods and compositions comprising rifabutin, clarithromycin, and clofazimine
granted -
US 9050263
Pharmaceutical compositions for the treatment of Helicobacter pylori
granted
Frequently asked questions
What is rifabutin?
rifabutin (MYCOBUTIN) is a bacterial dna-directed rna polymerase inhibitor. Associated with Pfizer Australia Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for rifabutin?
MYCOBUTIN is a marketed brand name for rifabutin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of rifabutin?
rifabutin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.